Gary Lee Feiss
Nessuna posizione attualmente
Profilo
Gary Lee Feiss held positions as Director of Clinical Trials at OraSure Technologies, Vice President of Regulatory Affairs at Covalent Group, and VP of Clinical Development & Regulatory Affairs at Saladax Biomedical.
Precedenti posizioni note di Gary Lee Feiss
| Società | Posizione | Fine |
|---|---|---|
| ORASURE TECHNOLOGIES, INC. | Corporate Officer/Principal | - |
| Covalent Group, Inc. | Consigliere Generale | - |
Saladax Biomedical, Inc.
 Saladax Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Saladax Biomedical, Inc. develops novel and commercializes diagnostic assays for the practical delivery of personalized medicine. Its products include pipeline, MY5-FU, mypaclitaxel, and mydocetaxel. MyCare product serves the central nervous system field, with antipsychotic drug dose management assays. The company was founded by Adrienne Choma and Salvatore J. Salamone in 2004 and is headquartered in Bethlehem, PA. | Consigliere Generale | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ORASURE TECHNOLOGIES, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Saladax Biomedical, Inc.
Saladax Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Saladax Biomedical, Inc. develops novel and commercializes diagnostic assays for the practical delivery of personalized medicine. Its products include pipeline, MY5-FU, mypaclitaxel, and mydocetaxel. MyCare product serves the central nervous system field, with antipsychotic drug dose management assays. The company was founded by Adrienne Choma and Salvatore J. Salamone in 2004 and is headquartered in Bethlehem, PA. | Commercial Services |
| Covalent Group, Inc. | Commercial Services |
- Borsa valori
- Insiders
- Gary Lee Feiss
